Surprising Study: LSD Use Makes Losing Your Job Feel Worse
A new study out of Germany says that LSD users have a harder time with losing than job than non-LSD users. Which is quite surprising.
Read Morelisteo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170
A new study out of Germany says that LSD users have a harder time with losing than job than non-LSD users. Which is quite surprising.
Read More
The psychedelic clinical trials and drug development pipeline has been busy the last few decades. And the future is looking bright.
Read More
Mt. Sinai's researchers may have found a groundbreaking connection between psychedelics and serotonin receptors and how they impact therapy.
Read More
Last reviewed and updated: July 4, 2026. Key Takeaways Phase 3 milestone Definium Therapeutics’ DT120 (LSD compound) completed Phase 3 clinical trials with positive results in June 2026 Anxiety evidence Multiple Phase 2 studies support LSD’s efficacy for anxiety disorders — both full-dose and low-dose protocols Microdose caution A 2025 RCT found LSD microdoses did […]
Read More
1P-LSD is a propionylated LSD analog that converts to LSD in the body. Same experience profile, dose, and duration as LSD. Federal Analogue Act controlled; explicitly scheduled in UK, Germany, Switzerland.
Read More
Is LSD legal in the U.S. or other countries? This guide explains the psychedelic's complex legal history.
Read More
What is LSD, and how does it impact people? This guide answers common questions about the psychedelic.
Read More
A nootropic drug is one that may enhance brain performance. And a new study suggests LSD may be classified in that class.
Read More